27.06.2007 11:00:00
|
Philips and University Medical Center Hamburg-Eppendorf to Test the World's First MRI/PET Image Software Tool for the Diagnosis of Neurodegenerative Diseases
The University Medical Center Hamburg-Eppendorf (UKE) and Royal Philips
Electronics have developed a computer aided diagnosis (CAD) system for
neurodegenerative diseases to support clinicians in diagnosing the onset
and type of disease as early as possible. The new diagnostic technique,
which has already proven its accuracy using historical image data and
known patient outcomes, is about to undergo clinical evaluation at UKE.
The CAD system is a software package that automatically interprets PET
(Positron Emission Tomography) brain scans of patients suspected of
having a neurodegenerative disease that leads to dementia, and combines
them with MRI (Magnetic Resonance Imaging) scans for accurate
differential diagnosis. The development of such a system will ultimately
mean a better quality of life for patients by enabling earlier
prescription of drugs that delay progression of the disease, and hence
delay the worst effects of dementia. It will also provide pharmaceutical
companies and clinicians with a valuable tool for the development and
testing of new, potentially curative drugs for neurodegenerative
diseases such as Alzheimer’s.
"In the not too distant future there is going
to be much greater demand for the accurate early diagnosis of
neurodegenerative disease and not everyone will have access to the
clinical expertise of a university hospital to obtain it,”
says Dr. Ralph Buchert of the Department of Nuclear Medicine at UKE. "The
availability of an automated system will help less experienced
physicians to achieve the same high level of accuracy in their diagnoses.”
Dementia is a debilitating condition that already affects more than 25
million people worldwide*, the commonest form being Alzheimer’s
disease. As the demographics of world populations increasingly shift
towards older age groups, dementia is widely expected to reach epidemic
proportions unless effective treatments are found for it.
"Building on our expertise in multi-modal
diagnostic imaging, we’ve combined functional
and structural brain-scan information into a fully integrated and easy
to use system for diagnosing the principal neurodegenerative diseases
that cause dementia,” says Dr. Lothar Spies,
Head of the Digital Imaging Department at Philips Research. "Ultimately,
it will enable early treatment and highly personalized therapies.”
The software tool developed by Philips Research and UKE accurately
overlays anatomical images of the brain obtained from MRI scans with PET
scans that display brain activity –
specifically the uptake of glucose that fuels brain activity. By using
advanced image processing and computer learning techniques in
combination with a database of reference brain-scans, the system then
analyses the images automatically and displays anomalous brain patterns
in a concise way. Based on these patterns, it then suggests a diagnosis.
As a result, the system will help less experienced doctors to achieve
the same diagnostic accuracy as highly trained specialists.
The clinical evaluation that is about to start will run the computer
aided diagnostic system alongside UKE’s
existing dementia diagnosis procedures with the aim of fine-tuning the
system’s ability to detect and differentiate
the three most common types of neurodegenerative disease –
Alzheimer’s Disease, Lewy-body Dementia and
Frontotemporal Dementia.
High resolution pictures can be downloaded from:
http://www.research.philips.com/newscenter/pictures/070627-caddeme
ntia-pict.html (Due to its length, this URL may need to be
copied/pasted into your Internet browser. Remove the extra space if one
exists.)
* Source: C. Ferri et al. Global prevalence of dementia: A Delphi
consensus study, Lancet 366, 2112-2117, DEC 2005.
About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a
global leader in healthcare, lifestyle and technology, delivering
products, services and solutions through the brand promise of "sense
and simplicity”. Headquartered in the
Netherlands, Philips employs approximately 124,300 employees in more
than 60 countries worldwide. With sales of EUR 27.0 billion in 2006, the
company is a market leader in medical diagnostic imaging and patient
monitoring systems, energy efficient lighting solutions, personal care
and home appliances, as well as consumer electronics. News from Philips
is located at www.philips.com/newscenter.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Philippine Long Distance Telephone Co. (PLDT) (Spons. ADRS)mehr Nachrichten
Keine Nachrichten verfügbar. |